factor VIII messenger RNA

**Factor VIII messenger RNA** is an investigational **mRNA-based drug** concept for **hemophilia A** in which synthetic messenger RNA encoding human coagulation factor VIII is delivered, typically using **lipid nanoparticles**, to enable host cells such as hepatocytes to transiently produce factor VIII protein and restore coagulation activity. Preclinical literature describes liver-directed LNP-formulated FVIII mRNA producing rapid, transient FVIII expression and correction of bleeding phenotypes in hemophilia A mouse models, but this appears to refer to a **platform/experimental therapeutic approach rather than a clearly identified single named clinical drug product**. The intended mechanism is endogenous expression of factor VIII protein, which then functions as a cofactor in the intrinsic coagulation cascade by supporting factor IXa-mediated activation of factor X. Because the query does not point to a unique branded or coded asset, the term is best treated as a nonspecific investigational RNA therapy concept rather than a single well-defined commercial or clinical-stage drug.

Other names

factor VIII messenger RNAfactor VIII mRNAFVIII mRNAF8 mRNAF-8 mRNAF 8 mRNA